Is Akebia Therapeutics Inc (NASDAQ: AKBA) Back In The Buying Zone?
Currently, there are 261.23M common shares owned by the public and among those 250.51M shares have been available to trade. The company’s stock has a 5-day price change of 12.50% and 0.00% over the past three months. AKBA shares are trading -0.53% year to date (YTD), with the 12-month market performance up to 29.45% higher. […]
Growth Story Still Intact For Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (AKBA) concluded trading on Wednesday at a closing price of $1.70, with 7.72 million shares of worth about $13.13 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 28.79% during that period and on April 09, 2025 the price saw a […]
Akebia Therapeutics Inc (AKBA) Testing Investors’ Patience Right Now
Currently, there are 261.23M common shares owned by the public and among those 250.51M shares have been available to trade. The company’s stock has a 5-day price change of -23.53% and 8.94% over the past three months. AKBA shares are trading 2.63% year to date (YTD), with the 12-month market performance down to -4.41% lower. […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Has Another Chance To Impress You
Currently, there are 236.23M common shares owned by the public and among those 226.53M shares have been available to trade. The company’s stock has a 5-day price change of 32.12% and 40.11% over the past three months. AKBA shares are trading 34.21% year to date (YTD), with the 12-month market performance up to 86.13% higher. […]
Technical Outlook And Game Plan For Akebia Therapeutics Inc (NASDAQ: AKBA)
Akebia Therapeutics Inc (AKBA) concluded trading on Thursday at a closing price of $1.69, with 9.6 million shares of worth about $16.23 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 14.19% during that period and on March 13, 2025 the price saw a […]
Akebia Therapeutics Inc. (NASDAQ: AKBA): To Buy Or Not To Buy, That Is The Question
Akebia Therapeutics Inc. (AKBA) concluded trading on Thursday at a closing price of $1.47, with 3.54 million shares of worth about $5.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.67% during that period and on Thursday the price saw a loss of […]
